J ANTIMICROB CHEMOTH 润色咨询

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

出版年份:1975 年文章数:7046 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:9.5% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=1092450, encodeId=f1461092450ad, content=为什么要从MeSH里筛选关键词?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092449, encodeId=08f810924498a, content=MeSH是什么东西?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=910797, encodeId=d26c910e9739, content=杂志对中国作者不友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201110/2d55d24dc5fd419d994b7b920c79731b/d3c8bdca983c4af1b90220a8192e353a.jpg, createdBy=e14e5296465, createdName=飞翔的乌龟, createdTime=Fri Dec 25 09:18:14 CST 2020, time=2020-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=852496, encodeId=e9068524965a, content=投稿7天被美国高级编辑拒,新意不够吧 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0175414027, createdName=ms5109743545865402, createdTime=Tue Jul 09 13:17:18 CST 2019, time=2019-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=839466, encodeId=001a83946607, content=审稿速度:6.0 | 投稿命中率:75.0<br>经验分享:编辑不友好。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30ac5413966, createdName=ms3908193925310106, createdTime=Wed Nov 22 19:24:28 CST 2017, time=2017-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548065, encodeId=06b8548065a2, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:9月9日完成投稿,10月5号左右waiting decision, 10月9日被拒。投稿系统里还没看到decision letter,还不知道什么原因。 这个杂志要求文字数量,需要严格参照稿约。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=280, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34ff61789, createdName=kobe24song, createdTime=Tue Oct 10 06:25:00 CST 2017, time=2017-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=835068, encodeId=c9bc835068db, content=拒稿理由是投稿文章太多 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7555414117, createdName=ms61234328952836, createdTime=Mon Dec 26 11:36:06 CST 2016, time=2016-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=834611, encodeId=ad138346115d, content=杂志对中国作者不友好 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eefb5414002, createdName=ms5441261199713928, createdTime=Wed Nov 16 11:23:18 CST 2016, time=2016-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=516070, encodeId=1dc45160e0df, content=哥发过几篇了哦,哪有什么难度哦~哥做微生物才不做这种耐药的低端套路哦~倒是做耐药的很难做出非耐药的哦~ <br> ---------------------------------------------------------------------------------- <br> 有本事你发个我看看!就按你说的套路估计连中文的都发不了!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=317, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92f41644362, createdName=Fan of Vibrio, createdTime=Sat Oct 17 19:24:00 CST 2015, time=2015-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=515972, encodeId=327a5159e263, content=有本事你发个我看看!就按你说的套路估计连中文的都发不了!<span class="quote">dyx4366 2015-08-28 发表::<br>接收率:约25% 审稿时间:约2个月 生科院做微生物的极少投这种耐药的杂志,反倒是疾控中心、兽医学院、食品学院或医院的在这种耐药杂志上大量发表文章。分分菌、做做PCR,交给公司测测序,没什么技术含量的低端套路。 </span>, beContent=dyx4366 2015-08-28 发表:: 接收率:约25% 审稿时间:约2个月 生科院做微生物的极少投这种耐药的杂志,反倒是疾控中心、兽医学院、食品学院或医院的在这种耐药杂志上大量发表文章。分分菌、做做PCR,交给公司测测序,没什么技术含量的低端套路。 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=334, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e121656486, createdName=banyuanjun58, createdTime=Thu Oct 15 13:10:00 CST 2015, time=2015-10-15, status=1, ipAttribution=)]
    2021-12-29 Mia

    为什么要从MeSH里筛选关键词?

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=1092450, encodeId=f1461092450ad, content=为什么要从MeSH里筛选关键词?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092449, encodeId=08f810924498a, content=MeSH是什么东西?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=910797, encodeId=d26c910e9739, content=杂志对中国作者不友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201110/2d55d24dc5fd419d994b7b920c79731b/d3c8bdca983c4af1b90220a8192e353a.jpg, createdBy=e14e5296465, createdName=飞翔的乌龟, createdTime=Fri Dec 25 09:18:14 CST 2020, time=2020-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=852496, encodeId=e9068524965a, content=投稿7天被美国高级编辑拒,新意不够吧 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0175414027, createdName=ms5109743545865402, createdTime=Tue Jul 09 13:17:18 CST 2019, time=2019-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=839466, encodeId=001a83946607, content=审稿速度:6.0 | 投稿命中率:75.0<br>经验分享:编辑不友好。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30ac5413966, createdName=ms3908193925310106, createdTime=Wed Nov 22 19:24:28 CST 2017, time=2017-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548065, encodeId=06b8548065a2, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:9月9日完成投稿,10月5号左右waiting decision, 10月9日被拒。投稿系统里还没看到decision letter,还不知道什么原因。 这个杂志要求文字数量,需要严格参照稿约。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=280, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34ff61789, createdName=kobe24song, createdTime=Tue Oct 10 06:25:00 CST 2017, time=2017-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=835068, encodeId=c9bc835068db, content=拒稿理由是投稿文章太多 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7555414117, createdName=ms61234328952836, createdTime=Mon Dec 26 11:36:06 CST 2016, time=2016-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=834611, encodeId=ad138346115d, content=杂志对中国作者不友好 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eefb5414002, createdName=ms5441261199713928, createdTime=Wed Nov 16 11:23:18 CST 2016, time=2016-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=516070, encodeId=1dc45160e0df, content=哥发过几篇了哦,哪有什么难度哦~哥做微生物才不做这种耐药的低端套路哦~倒是做耐药的很难做出非耐药的哦~ <br> ---------------------------------------------------------------------------------- <br> 有本事你发个我看看!就按你说的套路估计连中文的都发不了!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=317, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92f41644362, createdName=Fan of Vibrio, createdTime=Sat Oct 17 19:24:00 CST 2015, time=2015-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=515972, encodeId=327a5159e263, content=有本事你发个我看看!就按你说的套路估计连中文的都发不了!<span class="quote">dyx4366 2015-08-28 发表::<br>接收率:约25% 审稿时间:约2个月 生科院做微生物的极少投这种耐药的杂志,反倒是疾控中心、兽医学院、食品学院或医院的在这种耐药杂志上大量发表文章。分分菌、做做PCR,交给公司测测序,没什么技术含量的低端套路。 </span>, beContent=dyx4366 2015-08-28 发表:: 接收率:约25% 审稿时间:约2个月 生科院做微生物的极少投这种耐药的杂志,反倒是疾控中心、兽医学院、食品学院或医院的在这种耐药杂志上大量发表文章。分分菌、做做PCR,交给公司测测序,没什么技术含量的低端套路。 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=334, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e121656486, createdName=banyuanjun58, createdTime=Thu Oct 15 13:10:00 CST 2015, time=2015-10-15, status=1, ipAttribution=)]
    2021-12-28 衣谷

    MeSH是什么东西?

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=1092450, encodeId=f1461092450ad, content=为什么要从MeSH里筛选关键词?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092449, encodeId=08f810924498a, content=MeSH是什么东西?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=910797, encodeId=d26c910e9739, content=杂志对中国作者不友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201110/2d55d24dc5fd419d994b7b920c79731b/d3c8bdca983c4af1b90220a8192e353a.jpg, createdBy=e14e5296465, createdName=飞翔的乌龟, createdTime=Fri Dec 25 09:18:14 CST 2020, time=2020-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=852496, encodeId=e9068524965a, content=投稿7天被美国高级编辑拒,新意不够吧 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0175414027, createdName=ms5109743545865402, createdTime=Tue Jul 09 13:17:18 CST 2019, time=2019-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=839466, encodeId=001a83946607, content=审稿速度:6.0 | 投稿命中率:75.0<br>经验分享:编辑不友好。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30ac5413966, createdName=ms3908193925310106, createdTime=Wed Nov 22 19:24:28 CST 2017, time=2017-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548065, encodeId=06b8548065a2, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:9月9日完成投稿,10月5号左右waiting decision, 10月9日被拒。投稿系统里还没看到decision letter,还不知道什么原因。 这个杂志要求文字数量,需要严格参照稿约。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=280, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34ff61789, createdName=kobe24song, createdTime=Tue Oct 10 06:25:00 CST 2017, time=2017-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=835068, encodeId=c9bc835068db, content=拒稿理由是投稿文章太多 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7555414117, createdName=ms61234328952836, createdTime=Mon Dec 26 11:36:06 CST 2016, time=2016-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=834611, encodeId=ad138346115d, content=杂志对中国作者不友好 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eefb5414002, createdName=ms5441261199713928, createdTime=Wed Nov 16 11:23:18 CST 2016, time=2016-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=516070, encodeId=1dc45160e0df, content=哥发过几篇了哦,哪有什么难度哦~哥做微生物才不做这种耐药的低端套路哦~倒是做耐药的很难做出非耐药的哦~ <br> ---------------------------------------------------------------------------------- <br> 有本事你发个我看看!就按你说的套路估计连中文的都发不了!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=317, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92f41644362, createdName=Fan of Vibrio, createdTime=Sat Oct 17 19:24:00 CST 2015, time=2015-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=515972, encodeId=327a5159e263, content=有本事你发个我看看!就按你说的套路估计连中文的都发不了!<span class="quote">dyx4366 2015-08-28 发表::<br>接收率:约25% 审稿时间:约2个月 生科院做微生物的极少投这种耐药的杂志,反倒是疾控中心、兽医学院、食品学院或医院的在这种耐药杂志上大量发表文章。分分菌、做做PCR,交给公司测测序,没什么技术含量的低端套路。 </span>, beContent=dyx4366 2015-08-28 发表:: 接收率:约25% 审稿时间:约2个月 生科院做微生物的极少投这种耐药的杂志,反倒是疾控中心、兽医学院、食品学院或医院的在这种耐药杂志上大量发表文章。分分菌、做做PCR,交给公司测测序,没什么技术含量的低端套路。 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=334, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e121656486, createdName=banyuanjun58, createdTime=Thu Oct 15 13:10:00 CST 2015, time=2015-10-15, status=1, ipAttribution=)]
    2020-12-25 飞翔的乌龟

    杂志对中国作者不友好

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1092450, encodeId=f1461092450ad, content=为什么要从MeSH里筛选关键词?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092449, encodeId=08f810924498a, content=MeSH是什么东西?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=910797, encodeId=d26c910e9739, content=杂志对中国作者不友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201110/2d55d24dc5fd419d994b7b920c79731b/d3c8bdca983c4af1b90220a8192e353a.jpg, createdBy=e14e5296465, createdName=飞翔的乌龟, createdTime=Fri Dec 25 09:18:14 CST 2020, time=2020-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=852496, encodeId=e9068524965a, content=投稿7天被美国高级编辑拒,新意不够吧 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0175414027, createdName=ms5109743545865402, createdTime=Tue Jul 09 13:17:18 CST 2019, time=2019-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=839466, encodeId=001a83946607, content=审稿速度:6.0 | 投稿命中率:75.0<br>经验分享:编辑不友好。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30ac5413966, createdName=ms3908193925310106, createdTime=Wed Nov 22 19:24:28 CST 2017, time=2017-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548065, encodeId=06b8548065a2, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:9月9日完成投稿,10月5号左右waiting decision, 10月9日被拒。投稿系统里还没看到decision letter,还不知道什么原因。 这个杂志要求文字数量,需要严格参照稿约。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=280, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34ff61789, createdName=kobe24song, createdTime=Tue Oct 10 06:25:00 CST 2017, time=2017-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=835068, encodeId=c9bc835068db, content=拒稿理由是投稿文章太多 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7555414117, createdName=ms61234328952836, createdTime=Mon Dec 26 11:36:06 CST 2016, time=2016-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=834611, encodeId=ad138346115d, content=杂志对中国作者不友好 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eefb5414002, createdName=ms5441261199713928, createdTime=Wed Nov 16 11:23:18 CST 2016, time=2016-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=516070, encodeId=1dc45160e0df, content=哥发过几篇了哦,哪有什么难度哦~哥做微生物才不做这种耐药的低端套路哦~倒是做耐药的很难做出非耐药的哦~ <br> ---------------------------------------------------------------------------------- <br> 有本事你发个我看看!就按你说的套路估计连中文的都发不了!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=317, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92f41644362, createdName=Fan of Vibrio, createdTime=Sat Oct 17 19:24:00 CST 2015, time=2015-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=515972, encodeId=327a5159e263, content=有本事你发个我看看!就按你说的套路估计连中文的都发不了!<span class="quote">dyx4366 2015-08-28 发表::<br>接收率:约25% 审稿时间:约2个月 生科院做微生物的极少投这种耐药的杂志,反倒是疾控中心、兽医学院、食品学院或医院的在这种耐药杂志上大量发表文章。分分菌、做做PCR,交给公司测测序,没什么技术含量的低端套路。 </span>, beContent=dyx4366 2015-08-28 发表:: 接收率:约25% 审稿时间:约2个月 生科院做微生物的极少投这种耐药的杂志,反倒是疾控中心、兽医学院、食品学院或医院的在这种耐药杂志上大量发表文章。分分菌、做做PCR,交给公司测测序,没什么技术含量的低端套路。 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=334, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e121656486, createdName=banyuanjun58, createdTime=Thu Oct 15 13:10:00 CST 2015, time=2015-10-15, status=1, ipAttribution=)]
    2019-07-09 ms5109743545865402

    投稿7天被美国高级编辑拒,新意不够吧

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1092450, encodeId=f1461092450ad, content=为什么要从MeSH里筛选关键词?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092449, encodeId=08f810924498a, content=MeSH是什么东西?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=910797, encodeId=d26c910e9739, content=杂志对中国作者不友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201110/2d55d24dc5fd419d994b7b920c79731b/d3c8bdca983c4af1b90220a8192e353a.jpg, createdBy=e14e5296465, createdName=飞翔的乌龟, createdTime=Fri Dec 25 09:18:14 CST 2020, time=2020-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=852496, encodeId=e9068524965a, content=投稿7天被美国高级编辑拒,新意不够吧 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0175414027, createdName=ms5109743545865402, createdTime=Tue Jul 09 13:17:18 CST 2019, time=2019-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=839466, encodeId=001a83946607, content=审稿速度:6.0 | 投稿命中率:75.0<br>经验分享:编辑不友好。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30ac5413966, createdName=ms3908193925310106, createdTime=Wed Nov 22 19:24:28 CST 2017, time=2017-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548065, encodeId=06b8548065a2, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:9月9日完成投稿,10月5号左右waiting decision, 10月9日被拒。投稿系统里还没看到decision letter,还不知道什么原因。 这个杂志要求文字数量,需要严格参照稿约。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=280, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34ff61789, createdName=kobe24song, createdTime=Tue Oct 10 06:25:00 CST 2017, time=2017-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=835068, encodeId=c9bc835068db, content=拒稿理由是投稿文章太多 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7555414117, createdName=ms61234328952836, createdTime=Mon Dec 26 11:36:06 CST 2016, time=2016-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=834611, encodeId=ad138346115d, content=杂志对中国作者不友好 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eefb5414002, createdName=ms5441261199713928, createdTime=Wed Nov 16 11:23:18 CST 2016, time=2016-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=516070, encodeId=1dc45160e0df, content=哥发过几篇了哦,哪有什么难度哦~哥做微生物才不做这种耐药的低端套路哦~倒是做耐药的很难做出非耐药的哦~ <br> ---------------------------------------------------------------------------------- <br> 有本事你发个我看看!就按你说的套路估计连中文的都发不了!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=317, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92f41644362, createdName=Fan of Vibrio, createdTime=Sat Oct 17 19:24:00 CST 2015, time=2015-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=515972, encodeId=327a5159e263, content=有本事你发个我看看!就按你说的套路估计连中文的都发不了!<span class="quote">dyx4366 2015-08-28 发表::<br>接收率:约25% 审稿时间:约2个月 生科院做微生物的极少投这种耐药的杂志,反倒是疾控中心、兽医学院、食品学院或医院的在这种耐药杂志上大量发表文章。分分菌、做做PCR,交给公司测测序,没什么技术含量的低端套路。 </span>, beContent=dyx4366 2015-08-28 发表:: 接收率:约25% 审稿时间:约2个月 生科院做微生物的极少投这种耐药的杂志,反倒是疾控中心、兽医学院、食品学院或医院的在这种耐药杂志上大量发表文章。分分菌、做做PCR,交给公司测测序,没什么技术含量的低端套路。 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=334, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e121656486, createdName=banyuanjun58, createdTime=Thu Oct 15 13:10:00 CST 2015, time=2015-10-15, status=1, ipAttribution=)]
    2017-11-22 ms3908193925310106

    审稿速度:6.0 | 投稿命中率:75.0
    经验分享:编辑不友好。

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1092450, encodeId=f1461092450ad, content=为什么要从MeSH里筛选关键词?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092449, encodeId=08f810924498a, content=MeSH是什么东西?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=910797, encodeId=d26c910e9739, content=杂志对中国作者不友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201110/2d55d24dc5fd419d994b7b920c79731b/d3c8bdca983c4af1b90220a8192e353a.jpg, createdBy=e14e5296465, createdName=飞翔的乌龟, createdTime=Fri Dec 25 09:18:14 CST 2020, time=2020-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=852496, encodeId=e9068524965a, content=投稿7天被美国高级编辑拒,新意不够吧 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0175414027, createdName=ms5109743545865402, createdTime=Tue Jul 09 13:17:18 CST 2019, time=2019-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=839466, encodeId=001a83946607, content=审稿速度:6.0 | 投稿命中率:75.0<br>经验分享:编辑不友好。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30ac5413966, createdName=ms3908193925310106, createdTime=Wed Nov 22 19:24:28 CST 2017, time=2017-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548065, encodeId=06b8548065a2, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:9月9日完成投稿,10月5号左右waiting decision, 10月9日被拒。投稿系统里还没看到decision letter,还不知道什么原因。 这个杂志要求文字数量,需要严格参照稿约。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=280, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34ff61789, createdName=kobe24song, createdTime=Tue Oct 10 06:25:00 CST 2017, time=2017-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=835068, encodeId=c9bc835068db, content=拒稿理由是投稿文章太多 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7555414117, createdName=ms61234328952836, createdTime=Mon Dec 26 11:36:06 CST 2016, time=2016-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=834611, encodeId=ad138346115d, content=杂志对中国作者不友好 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eefb5414002, createdName=ms5441261199713928, createdTime=Wed Nov 16 11:23:18 CST 2016, time=2016-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=516070, encodeId=1dc45160e0df, content=哥发过几篇了哦,哪有什么难度哦~哥做微生物才不做这种耐药的低端套路哦~倒是做耐药的很难做出非耐药的哦~ <br> ---------------------------------------------------------------------------------- <br> 有本事你发个我看看!就按你说的套路估计连中文的都发不了!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=317, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92f41644362, createdName=Fan of Vibrio, createdTime=Sat Oct 17 19:24:00 CST 2015, time=2015-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=515972, encodeId=327a5159e263, content=有本事你发个我看看!就按你说的套路估计连中文的都发不了!<span class="quote">dyx4366 2015-08-28 发表::<br>接收率:约25% 审稿时间:约2个月 生科院做微生物的极少投这种耐药的杂志,反倒是疾控中心、兽医学院、食品学院或医院的在这种耐药杂志上大量发表文章。分分菌、做做PCR,交给公司测测序,没什么技术含量的低端套路。 </span>, beContent=dyx4366 2015-08-28 发表:: 接收率:约25% 审稿时间:约2个月 生科院做微生物的极少投这种耐药的杂志,反倒是疾控中心、兽医学院、食品学院或医院的在这种耐药杂志上大量发表文章。分分菌、做做PCR,交给公司测测序,没什么技术含量的低端套路。 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=334, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e121656486, createdName=banyuanjun58, createdTime=Thu Oct 15 13:10:00 CST 2015, time=2015-10-15, status=1, ipAttribution=)]
    2017-10-10 kobe24song

    审稿速度:1.0 | 投稿命中率:25.0
    经验分享:9月9日完成投稿,10月5号左右waiting decision, 10月9日被拒。投稿系统里还没看到decision letter,还不知道什么原因。 这个杂志要求文字数量,需要严格参照稿约。

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1092450, encodeId=f1461092450ad, content=为什么要从MeSH里筛选关键词?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092449, encodeId=08f810924498a, content=MeSH是什么东西?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=910797, encodeId=d26c910e9739, content=杂志对中国作者不友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201110/2d55d24dc5fd419d994b7b920c79731b/d3c8bdca983c4af1b90220a8192e353a.jpg, createdBy=e14e5296465, createdName=飞翔的乌龟, createdTime=Fri Dec 25 09:18:14 CST 2020, time=2020-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=852496, encodeId=e9068524965a, content=投稿7天被美国高级编辑拒,新意不够吧 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0175414027, createdName=ms5109743545865402, createdTime=Tue Jul 09 13:17:18 CST 2019, time=2019-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=839466, encodeId=001a83946607, content=审稿速度:6.0 | 投稿命中率:75.0<br>经验分享:编辑不友好。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30ac5413966, createdName=ms3908193925310106, createdTime=Wed Nov 22 19:24:28 CST 2017, time=2017-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548065, encodeId=06b8548065a2, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:9月9日完成投稿,10月5号左右waiting decision, 10月9日被拒。投稿系统里还没看到decision letter,还不知道什么原因。 这个杂志要求文字数量,需要严格参照稿约。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=280, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34ff61789, createdName=kobe24song, createdTime=Tue Oct 10 06:25:00 CST 2017, time=2017-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=835068, encodeId=c9bc835068db, content=拒稿理由是投稿文章太多 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7555414117, createdName=ms61234328952836, createdTime=Mon Dec 26 11:36:06 CST 2016, time=2016-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=834611, encodeId=ad138346115d, content=杂志对中国作者不友好 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eefb5414002, createdName=ms5441261199713928, createdTime=Wed Nov 16 11:23:18 CST 2016, time=2016-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=516070, encodeId=1dc45160e0df, content=哥发过几篇了哦,哪有什么难度哦~哥做微生物才不做这种耐药的低端套路哦~倒是做耐药的很难做出非耐药的哦~ <br> ---------------------------------------------------------------------------------- <br> 有本事你发个我看看!就按你说的套路估计连中文的都发不了!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=317, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92f41644362, createdName=Fan of Vibrio, createdTime=Sat Oct 17 19:24:00 CST 2015, time=2015-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=515972, encodeId=327a5159e263, content=有本事你发个我看看!就按你说的套路估计连中文的都发不了!<span class="quote">dyx4366 2015-08-28 发表::<br>接收率:约25% 审稿时间:约2个月 生科院做微生物的极少投这种耐药的杂志,反倒是疾控中心、兽医学院、食品学院或医院的在这种耐药杂志上大量发表文章。分分菌、做做PCR,交给公司测测序,没什么技术含量的低端套路。 </span>, beContent=dyx4366 2015-08-28 发表:: 接收率:约25% 审稿时间:约2个月 生科院做微生物的极少投这种耐药的杂志,反倒是疾控中心、兽医学院、食品学院或医院的在这种耐药杂志上大量发表文章。分分菌、做做PCR,交给公司测测序,没什么技术含量的低端套路。 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=334, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e121656486, createdName=banyuanjun58, createdTime=Thu Oct 15 13:10:00 CST 2015, time=2015-10-15, status=1, ipAttribution=)]
    2016-12-26 ms61234328952836

    拒稿理由是投稿文章太多

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1092450, encodeId=f1461092450ad, content=为什么要从MeSH里筛选关键词?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092449, encodeId=08f810924498a, content=MeSH是什么东西?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=910797, encodeId=d26c910e9739, content=杂志对中国作者不友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201110/2d55d24dc5fd419d994b7b920c79731b/d3c8bdca983c4af1b90220a8192e353a.jpg, createdBy=e14e5296465, createdName=飞翔的乌龟, createdTime=Fri Dec 25 09:18:14 CST 2020, time=2020-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=852496, encodeId=e9068524965a, content=投稿7天被美国高级编辑拒,新意不够吧 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0175414027, createdName=ms5109743545865402, createdTime=Tue Jul 09 13:17:18 CST 2019, time=2019-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=839466, encodeId=001a83946607, content=审稿速度:6.0 | 投稿命中率:75.0<br>经验分享:编辑不友好。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30ac5413966, createdName=ms3908193925310106, createdTime=Wed Nov 22 19:24:28 CST 2017, time=2017-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548065, encodeId=06b8548065a2, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:9月9日完成投稿,10月5号左右waiting decision, 10月9日被拒。投稿系统里还没看到decision letter,还不知道什么原因。 这个杂志要求文字数量,需要严格参照稿约。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=280, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34ff61789, createdName=kobe24song, createdTime=Tue Oct 10 06:25:00 CST 2017, time=2017-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=835068, encodeId=c9bc835068db, content=拒稿理由是投稿文章太多 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7555414117, createdName=ms61234328952836, createdTime=Mon Dec 26 11:36:06 CST 2016, time=2016-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=834611, encodeId=ad138346115d, content=杂志对中国作者不友好 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eefb5414002, createdName=ms5441261199713928, createdTime=Wed Nov 16 11:23:18 CST 2016, time=2016-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=516070, encodeId=1dc45160e0df, content=哥发过几篇了哦,哪有什么难度哦~哥做微生物才不做这种耐药的低端套路哦~倒是做耐药的很难做出非耐药的哦~ <br> ---------------------------------------------------------------------------------- <br> 有本事你发个我看看!就按你说的套路估计连中文的都发不了!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=317, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92f41644362, createdName=Fan of Vibrio, createdTime=Sat Oct 17 19:24:00 CST 2015, time=2015-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=515972, encodeId=327a5159e263, content=有本事你发个我看看!就按你说的套路估计连中文的都发不了!<span class="quote">dyx4366 2015-08-28 发表::<br>接收率:约25% 审稿时间:约2个月 生科院做微生物的极少投这种耐药的杂志,反倒是疾控中心、兽医学院、食品学院或医院的在这种耐药杂志上大量发表文章。分分菌、做做PCR,交给公司测测序,没什么技术含量的低端套路。 </span>, beContent=dyx4366 2015-08-28 发表:: 接收率:约25% 审稿时间:约2个月 生科院做微生物的极少投这种耐药的杂志,反倒是疾控中心、兽医学院、食品学院或医院的在这种耐药杂志上大量发表文章。分分菌、做做PCR,交给公司测测序,没什么技术含量的低端套路。 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=334, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e121656486, createdName=banyuanjun58, createdTime=Thu Oct 15 13:10:00 CST 2015, time=2015-10-15, status=1, ipAttribution=)]
    2016-11-16 ms5441261199713928

    杂志对中国作者不友好

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1092450, encodeId=f1461092450ad, content=为什么要从MeSH里筛选关键词?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092449, encodeId=08f810924498a, content=MeSH是什么东西?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=910797, encodeId=d26c910e9739, content=杂志对中国作者不友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201110/2d55d24dc5fd419d994b7b920c79731b/d3c8bdca983c4af1b90220a8192e353a.jpg, createdBy=e14e5296465, createdName=飞翔的乌龟, createdTime=Fri Dec 25 09:18:14 CST 2020, time=2020-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=852496, encodeId=e9068524965a, content=投稿7天被美国高级编辑拒,新意不够吧 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0175414027, createdName=ms5109743545865402, createdTime=Tue Jul 09 13:17:18 CST 2019, time=2019-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=839466, encodeId=001a83946607, content=审稿速度:6.0 | 投稿命中率:75.0<br>经验分享:编辑不友好。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30ac5413966, createdName=ms3908193925310106, createdTime=Wed Nov 22 19:24:28 CST 2017, time=2017-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548065, encodeId=06b8548065a2, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:9月9日完成投稿,10月5号左右waiting decision, 10月9日被拒。投稿系统里还没看到decision letter,还不知道什么原因。 这个杂志要求文字数量,需要严格参照稿约。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=280, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34ff61789, createdName=kobe24song, createdTime=Tue Oct 10 06:25:00 CST 2017, time=2017-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=835068, encodeId=c9bc835068db, content=拒稿理由是投稿文章太多 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7555414117, createdName=ms61234328952836, createdTime=Mon Dec 26 11:36:06 CST 2016, time=2016-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=834611, encodeId=ad138346115d, content=杂志对中国作者不友好 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eefb5414002, createdName=ms5441261199713928, createdTime=Wed Nov 16 11:23:18 CST 2016, time=2016-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=516070, encodeId=1dc45160e0df, content=哥发过几篇了哦,哪有什么难度哦~哥做微生物才不做这种耐药的低端套路哦~倒是做耐药的很难做出非耐药的哦~ <br> ---------------------------------------------------------------------------------- <br> 有本事你发个我看看!就按你说的套路估计连中文的都发不了!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=317, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92f41644362, createdName=Fan of Vibrio, createdTime=Sat Oct 17 19:24:00 CST 2015, time=2015-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=515972, encodeId=327a5159e263, content=有本事你发个我看看!就按你说的套路估计连中文的都发不了!<span class="quote">dyx4366 2015-08-28 发表::<br>接收率:约25% 审稿时间:约2个月 生科院做微生物的极少投这种耐药的杂志,反倒是疾控中心、兽医学院、食品学院或医院的在这种耐药杂志上大量发表文章。分分菌、做做PCR,交给公司测测序,没什么技术含量的低端套路。 </span>, beContent=dyx4366 2015-08-28 发表:: 接收率:约25% 审稿时间:约2个月 生科院做微生物的极少投这种耐药的杂志,反倒是疾控中心、兽医学院、食品学院或医院的在这种耐药杂志上大量发表文章。分分菌、做做PCR,交给公司测测序,没什么技术含量的低端套路。 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=334, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e121656486, createdName=banyuanjun58, createdTime=Thu Oct 15 13:10:00 CST 2015, time=2015-10-15, status=1, ipAttribution=)]
    2015-10-17 Fan of Vibrio

    哥发过几篇了哦,哪有什么难度哦~哥做微生物才不做这种耐药的低端套路哦~倒是做耐药的很难做出非耐药的哦~
    ----------------------------------------------------------------------------------
    有本事你发个我看看!就按你说的套路估计连中文的都发不了!

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=1092450, encodeId=f1461092450ad, content=为什么要从MeSH里筛选关键词?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092449, encodeId=08f810924498a, content=MeSH是什么东西?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=910797, encodeId=d26c910e9739, content=杂志对中国作者不友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201110/2d55d24dc5fd419d994b7b920c79731b/d3c8bdca983c4af1b90220a8192e353a.jpg, createdBy=e14e5296465, createdName=飞翔的乌龟, createdTime=Fri Dec 25 09:18:14 CST 2020, time=2020-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=852496, encodeId=e9068524965a, content=投稿7天被美国高级编辑拒,新意不够吧 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0175414027, createdName=ms5109743545865402, createdTime=Tue Jul 09 13:17:18 CST 2019, time=2019-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=839466, encodeId=001a83946607, content=审稿速度:6.0 | 投稿命中率:75.0<br>经验分享:编辑不友好。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30ac5413966, createdName=ms3908193925310106, createdTime=Wed Nov 22 19:24:28 CST 2017, time=2017-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548065, encodeId=06b8548065a2, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:9月9日完成投稿,10月5号左右waiting decision, 10月9日被拒。投稿系统里还没看到decision letter,还不知道什么原因。 这个杂志要求文字数量,需要严格参照稿约。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=280, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34ff61789, createdName=kobe24song, createdTime=Tue Oct 10 06:25:00 CST 2017, time=2017-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=835068, encodeId=c9bc835068db, content=拒稿理由是投稿文章太多 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7555414117, createdName=ms61234328952836, createdTime=Mon Dec 26 11:36:06 CST 2016, time=2016-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=834611, encodeId=ad138346115d, content=杂志对中国作者不友好 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eefb5414002, createdName=ms5441261199713928, createdTime=Wed Nov 16 11:23:18 CST 2016, time=2016-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=516070, encodeId=1dc45160e0df, content=哥发过几篇了哦,哪有什么难度哦~哥做微生物才不做这种耐药的低端套路哦~倒是做耐药的很难做出非耐药的哦~ <br> ---------------------------------------------------------------------------------- <br> 有本事你发个我看看!就按你说的套路估计连中文的都发不了!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=317, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92f41644362, createdName=Fan of Vibrio, createdTime=Sat Oct 17 19:24:00 CST 2015, time=2015-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=515972, encodeId=327a5159e263, content=有本事你发个我看看!就按你说的套路估计连中文的都发不了!<span class="quote">dyx4366 2015-08-28 发表::<br>接收率:约25% 审稿时间:约2个月 生科院做微生物的极少投这种耐药的杂志,反倒是疾控中心、兽医学院、食品学院或医院的在这种耐药杂志上大量发表文章。分分菌、做做PCR,交给公司测测序,没什么技术含量的低端套路。 </span>, beContent=dyx4366 2015-08-28 发表:: 接收率:约25% 审稿时间:约2个月 生科院做微生物的极少投这种耐药的杂志,反倒是疾控中心、兽医学院、食品学院或医院的在这种耐药杂志上大量发表文章。分分菌、做做PCR,交给公司测测序,没什么技术含量的低端套路。 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=334, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e121656486, createdName=banyuanjun58, createdTime=Thu Oct 15 13:10:00 CST 2015, time=2015-10-15, status=1, ipAttribution=)]
    2015-10-15 banyuanjun58

    有本事你发个我看看!就按你说的套路估计连中文的都发不了!dyx4366 2015-08-28 发表::
    接收率:约25% 审稿时间:约2个月 生科院做微生物的极少投这种耐药的杂志,反倒是疾控中心、兽医学院、食品学院或医院的在这种耐药杂志上大量发表文章。分分菌、做做PCR,交给公司测测序,没什么技术含量的低端套路。

    dyx4366 2015-08-28 发表:: 接收率:约25% 审稿时间:约2个月 生科院做微生物的极少投这种耐药的杂志,反倒是疾控中心、兽医学院、食品学院或医院的在这种耐药杂志上大量发表文章。分分菌、做做PCR,交给公司测测序,没什么技术含量的低端套路。

    0

共42条页码: 2/5页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分